The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImage Scan Holdings Regulatory News (IGE)

Share Price Information for Image Scan Holdings (IGE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.35
Bid: 1.20
Ask: 1.50
Change: 0.00 (0.00%)
Spread: 0.30 (25.00%)
Open: 1.35
High: 1.35
Low: 1.35
Prev. Close: 1.35
IGE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-Close Trading Update

3 Nov 2021 07:00

RNS Number : 1185R
Image Scan Holdings PLC
03 November 2021
 

03/11/2021

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain

 

IMAGE SCAN HOLDINGS PLC

("Image Scan" or the "Company")

 

PRE-CLOSE TRADING UPDATE

 

Image Scan (AIM: IGE), the specialist supplier of X-ray screening systems to the security and industrial inspection markets provides a pre-close trading update of its unaudited results for the year ended 30 September 2021.

Key Points:

· Order bookings increased to £2.8m (2020: £2.4m)

· Sales fell to £2.9m following weak first half (2020: £3.5m).

· Gross margin increased to 53% (2020: 49%)

· Strong control of overheads, reduced 18% to £1.3m (2020: £1.6m)

· Reportable unaudited pre-tax trading profit of £189k (2020: £112k)

· Pre-tax trading profit (adjusted for capitalized R&D spend) £98k (2020: £112k)

· First orders for new cabinet X-ray systems

· First orders for government customers in the USA

· Period-end order book of £516k (2020: £633k)

· Strong year-end cash balance of £1.2m (2020: £1.4m)

 

The COVID-19 pandemic continued to impact activity, with foreign travel for trade shows, sales presentations and in-person customer service only starting to become possible at the very end of the period. Despite the challenges, the business traded throughout the pandemic and careful management of overheads allowed it to make a profit whilst continuing with its ambitious new product development programme.

New orders increased to £2.8m (2020: £2.4m) and included both sales of new products, such as the Axis-CXi cabinet X-ray system, and sales to new customers in new territories. Among the new customer sales, those to government agencies in the USA and Canada were particularly significant, as the Company has invested in developing these important markets. Following a weak first half, sales strengthened to reach £2.9m (2020: £3.5m) at year-end and included a 30-unit portable X-ray sale to an Asian government. Margins were strong at 53% (2020: 49%).

A significant decrease in overheads to £1.3m (2020: £1.6m) reflected lower travel costs caused by the COVID-19 pandemic, a reduction in trade show costs, and judicious use of the Government furlough scheme in quieter periods. This, together with the strong margins, led to an unaudited pre-tax trading profit, calculated on the same basis as the prior year, of £98k (2020: £112k).

Much of the product development effort to the Company is now focussed on development of new product ranges, such as cabinet and conveyor X-ray systems which are expected to generate new revenue streams for the business. The Company is therefore in a position to implement the policy of capitalising its new product development spend under IAS38 Intangible Assets. The adoption of this policy is expected to increase the reportable pre-tax profit for the year by £91k to £189k. 

Stock has continued to be tightly managed, although global disruption in supply chains for a variety of components and commodities has forced the Company to start buying critical items for stock as they become available. This has yet to significantly impact stock levels or delivery times but will continue to require careful management going forward. The Company finished the year with an order book of £516k (2020: £633k) and a healthy cash balance £1.2m (2020: £1.4m).

The new product development programme continued to make good progress and launches of both portable and conveyor X-ray systems are anticipated for early in FY 2022. The R&D team has delivered a new suite of measurement techniques to a key industrial customer, and it is hoped this will lead to wider adoption of our industrial inspection systems.

Image Scan's Chairman and Chief Executive, Bill Mawer, commented:

"The COVID-19 pandemic has continued to impact all aspects of the business. Launching a new product without being able to visit customers or attend trade shows has presented a considerable challenge, as has servicing our widely deployed industrial X-ray machines. However, first orders were received for the new product, our industrial service contracts have been delivered, and it is pleasing to report a profit for the second year in succession. Disruption to global supply chains remains a concern but, with more product launches planned for the new year, and a world that is starting to adjust to the presence of COVID-19, we retain our optimistic outlook for the future."

 

 

 

For further information on the Company, please visit: www.ish.co.uk and for further information on its products, please visit: www.3dx-ray.com

 

 

 

Enquiries:

 

Image Scan Holdings plc

William Mawer, Chairman and Chief Executive Officer

Sarah Atwell King, Finance Director and Company Secretary

Tel: +44 (0) 1509 817 400

ir@ish.co.uk

W H Ireland

Mike Coe/Sarah Mather (Corporate Finance)

 

Tel: +44 (0) 117 945 3470

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFSMFMEEFSEDF
Date   Source Headline
2nd Oct 200810:45 amRNSEPT Disclosure
30th Sep 20087:00 amRNSPre-Close Trading Update
30th Jun 20087:00 amRNSCollaboration with British Tr
9th Jun 20087:00 amRNSInterim Results
3rd Apr 20087:00 amRNSMultiple New Contract Wins
13th Mar 200812:18 pmRNSAGM Statement
13th Mar 20087:00 amRNSTrading Update
31st Jan 20087:00 amRNSPreliminary Results
30th Nov 20074:33 pmRNSNew Chairman Appointed
29th Nov 20077:00 amRNSGrowing Demand Lifts Sales
14th Nov 20077:01 amRNSDirectorate Changes
12th Nov 20077:00 amRNSIssue of Shares
7th Nov 200710:02 amRNSHolding(s) in Company
5th Nov 20077:00 amRNSBoard Change
25th Sep 20077:02 amRNSContract win
13th Sep 20077:00 amRNSPre-close Trading Update
16th Aug 20073:13 pmRNSRule 26 Website
26th Jul 20071:00 pmRNSBoard Change
25th Jun 20077:01 amRNSHolding(s) in Company
21st Jun 20077:00 amRNSHolding(s) in Company
18th Jun 20079:14 amRNSHolding(s) in Company
14th Jun 20073:06 pmRNSEGM Statement
21st May 200712:22 pmRNSChange of Adviser
21st May 200712:18 pmRNSShare Placing/Trading update
21st May 200712:10 pmRNSInterim Results
20th Apr 200710:05 amRNSDirector/PDMR Shareholding
23rd Mar 200712:00 pmRNSResult of AGM
27th Feb 20077:01 amRNSHolding(s) in Company
15th Jan 20077:00 amRNSFinal Results
21st Dec 20067:00 amRNSHolding(s) in Company
14th Dec 20067:01 amRNSHolding(s) in Company
12th Dec 20068:00 amRNSTotal Voting Rights
14th Nov 20067:01 amRNSTrading Statement
13th Dec 20057:00 amPRNFinal Results
1st Nov 200512:00 pmPRNDate of Preliminary Results
1st Nov 200512:00 pmPRNDate of Preliminary Results
21st Oct 20056:00 amPRNNew Rapiscan Agreement
3rd Oct 20059:00 amPRNIssue of Options
13th Sep 20056:00 amPRNRe Contract
12th Aug 20056:30 amPRNRe Contract
29th Jul 20054:44 pmPRNDirectorate Change
5th Jul 20052:30 pmRNSSAR 5 - Image Scan-Replacemnt
1st Jul 200512:20 pmRNSSAR 5 - Image Scan Holdings
3rd Jun 20059:40 amPRNHolding(s) in Company
1st Jun 20056:30 amPRNInterim Results
31st May 20059:39 amPRNDirectorate Change
17th May 200510:15 amRNSLicensing Agreement
27th Apr 20052:29 pmRNSDirectors Shareholding
26th Apr 20052:15 pmRNSPlacing and Open Offer
26th Apr 20057:00 amRNSAGM and EGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.